JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Johnson & Johnson Enterprise Innovation Inc.
Johnson & Johnson Enterprise Innovation Inc.
Merck Sharp & Dohme LLC
DEKA Biosciences
Eurofarma Laboratorios S.A.
EpicentRx, Inc.
CEL-SCI Corporation
PharmaEngine
BioMimetix JV, LLC
Bristol-Myers Squibb
Curis, Inc.
Swedish Orphan Biovitrum
GlaxoSmithKline
Piramal Enterprises Limited
Boehringer Ingelheim
Piramal Enterprises Limited
Sanofi
AstraZeneca
GlaxoSmithKline
Sanofi
AstraZeneca
AstraZeneca
AstraZeneca